Stocktoria
ROCKWELL MEDICAL, INC. RMTI
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1998-01-27
ROCKWELL MEDICAL, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 16.9% | 17.2% | 10.4% | 5.6% | -3.9% |
| Operating margin | -6.8% | 0.6% | -8.0% | -23.0% | -49.0% |
| Net margin | -7.7% | -0.5% | -10.1% | -25.7% | -52.8% |
| Return on assets | -9.3% | -0.8% | -16.2% | -40.1% | -67.3% |
| Return on equity | -14.4% | -1.5% | -39.6% | -132.4% | -1288.9% |
| Debt / equity | 0.24× | 0.26× | 0.39× | 0.54× | 5.20× |
| Current ratio | 3.98 | 2.63 | 1.73 | 2.00 | 1.68 |
| Revenue growth | -31.8% | 21.4% | 14.8% | 17.6% | -0.4% |
Source: SEC EDGAR filings · CIK 0001041024 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.